Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Age
18–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
ECOG 0-2. Aged 18-70 years old. Pathologically diagnosed as breast cancer. Need to receive radiotherapy according to guidelines. Radiotherapy target volume included chest wall/breast with or without lymph node regions.
Need to receive one of the following therapies according to guidelines, capetabine, CDK4/6 inhibitor, PARP inhibitor , ICIs , HER2 inhibitors.
You may not be if
Male breast cancer. Allergy to the upper medicines before. Will receive trastuzumab alone during and/or after radiotherapy. With severe other disease.
Clareo Health | Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
